Comment
Enteric pathogens were never isolated in this case, and the epidemiological history did not support the possibility of infection from such pathogens. Thus the repeated isolation of Str pyogenes from the patient's faeces and rectal swab suggested that this organism was probably associated with the illness. Furthermore, clinical and bacteriological cures were achieved simultaneously when she was treated with the antibiotics to which Str pyogenes was sensitive. The usual practice of culturing stools on selective media did not grow Str pyogenes, and the diagnosis would have been missed if blood-agar media had not been used.
Despite an extensive search I have not found any other report of diarrhoea or dysentery caused by this organism. The source of infection in this case could not be established. The organism colonised the vagina and gut leaving the nose and throat free, but such colonisation is not particularly uncommon.3 The absence of signs or symptoms of systemic illness and the normal white cell count and antistreptolysin 0 titres excluded blood-borne infection. Normally either penicillin or erythromycin would be chosen for Str pyogenes infections, but in this case both were prescribed because of uncertainty of their effect on this organism in the gut. Severe hypophosphataemia in T-cell lymphoblastic lymphoma
In the treatment of lymphoma or leukaemia the metabolic derangements accompanying tumour lysis include potentially fatal hyperkalaemia or hyperphosphataemia, hypocalcaemia, and hyperuricaemia, complicated in some instances by renal failure.'
We report an unusual patient with T-cell lymphoblastic lymphoma in whom recurrent symptomatic hypophosphataemia occurred in parallel with an increase in tumour burden and chemotherapy was accompanied by predictable episodes of hyperphosphataemia and hypocalcaemia.
Case report
A 26-year-old woman presented with a two-week history of generalised malaise, easy bruising, and menorrhagia. Examination disclosed, besides widespread ecchymoses and nodular skin infiltrates, generalised lymphadenopathy and hepatosplenomegaly. Results of investigations were: haemoglobin concenltration 13-3 g/dl, white cell count lOOX 109/l (90a' lymphoblasts), platelet count 30x 10 /l. The chest radiograph showed massive anterior mediastinal lymph-node enlargement, and biopsy findings of the skin nodules and cervical nodes were consistent with lymphoblastic lymphoma. Immunological characterisation of this tissue, together with peripheral blood lymphoblasts, confirmed the diagnosis of T-cell lymphoblastic lymphoma. Serum biochemical values were: urate 0-76 mmol/l (12 8 mg/100 ml), creatinine 130-0 ismol/l (1-5 mg/100 ml), calcium 2-52 mmol/l (10-1 mg/100 ml), phosphate 1-27 mmol/l (3 9 mg/100 ml), and lactate dehydrogenase 1694 U/l.
Treatment was begun with intravenous hydration, allopurinol, and combination chemotherapy (CHOP) with cyclophosphamide (750 mg/M2), adriamycin (50 mg/M2), vincristine (1-4 mg/M2), and prednisolone (60 mg/M2) on days 1 to 5. Twenty-four hours after chemotherapy the serum phosphate concentration was 3-36 mmol/l (10-4 mg/100 ml) and lactate dehydrogenase activity 2574 U/l. The lymphadenopathy and organ enlargement rapidly resolved over the ensuing week. CHOP was administered at monthly intervals but five months after presentation cranial irradiation together with intrathecal methotrexate were required because of symptomatic cerebral lymphomatous spread. Chemotherapy was changed to L-asparaginase (colaspase), 10 000 U/M2, and cytosine arabinoside (cytarabine), 200 mg/M2, on days 1 to 5, administered at monthly intervals. Recurrence in the central nervous system necessitating irradiation occurred 10 months after presentation, and chemotherapy was altered to a monthly CHOP and L-asparaginase regimen.
Sixteen months after diagnosis the patient complained of profound muscle weakness, arthralgia, perioral paraesthesia, and sensitivity of the teeth. Gross lymphadenopathy and hepatosplenomegaly were present. The table lists the pertinent haematological and biochemical findings. The most notable feature was the severe hypophosphataemia, and urinary phosphate was not detectable. After chemotherapy the typical features of the tumour lysis syndrome with hyperphosphataemia, hypocalcaemia, and renal insufficiency (table) occurred concomitantly with a rapid reduction of peripheral blood lymphoblasts; return of plasma phosphate concentrations to normal was accompanied by normal urinary phosphate excretion.
Peripheral blood metabolic changes in patient with T lymphoblastic lymphoma 1 yLmol/l _ 0-01 mg/l00ml. Calcium: 1 mmol/l _ 4-0 mg/100 ml. Phosphate: 1 mmol/l 3-1 mg/100 ml. Urate: 1 mmol/l 16-8 mg'/100 ml.
Over the next three months the patient regularly presented with symptoms reflecting profound hypophosphataemia; chemotherapy produced predictable hyperphosphataemia and hypocalcaemia on each occasion. Eighteen months after presentation she died of Streptococcus vi-idans meningitis and septicaemia during a period of neutropenia. Necropsy showed diffuse lymphoblastic lymphoma affecting liver, pancreas, spleen, small bowel, lungs, kidneys, and brain.
Comment
This patient had pronounced symptomatic hypophosphataemia without any of the common predisposing factors for phosphate depletion, including chronic diarrhoea.2 Heparinised whole blood obtained during the period of hypophosphataemia was assayed immediately after venesection and incubation at 37°C and no differences in serial phosphate concentrations suggested that the observed hypophosphataemia was not simply an in-vitro effect. Although the metabolic sequelae of rapid tumour lysis, observed in our patient, are well documented,1 the profound antecedent hypophosphataemia must be either extremely rare or unrecognised, being previously described in only two patients with acute leukaemia.4
The cause of the hypophosphataemia is obscure. Generally it occurs in association with pronounced degrees of leukocytosis, and both the redistribution of extracellular phosphate into rapidly dividing malignant cells together with the greatly increased neoplastic mass may be contributing factors. Its clinical importance lies in the recognition that hypophosphataemia under these circumstances does cause morbidity and appears to be a premonitory finding for chemotherapy-induced hyperphosphataemia and hypocalcaemia requiring vigorous electrolyte monitoring and therapeutic intervention to reduce the morbidity associated with this tumour lysis syndrome. In 1978 we reported our findings in the Oxford Family Planning Association study on the return of fertility in women stopping birth control to plan a pregnancy.' Data on users of intrauterine contraceptive devices were sparse but like those reported by others2 gave no cause for concern. In this paper we present our latest results on fertility in ex-users of an intrauterine device, including for the first time information on those who had a device removed for medical reasons.
Subjects, methods, and results
The methods used in the Oxford Family Planning Association study have been described.3 The study includes over 17 000 women who, when recruited between 1968 and 1974, were all married and aged 25-39 years.
Information on the date of the last menstrual period is not collected in our study so the analyses presented here relate to cumulative outcome rates rather than cumulative conception rates. A live birth or stillbirth was taken as the relevant outcome and the rates were calculated by routine life-table techniques. Women entered the analysis on stopping contraception to plan a pregnancy and left it when any of the following occurred: (a) live birth or stillbirth; (b) end of, or loss to, follow-up; (c) resumption of contraception. Women stopping birth control to plan a pregnancy more than once were included in our analyses on each occasion.
Data on nulliparous ex-users of an intrauterine device were too few for analysis so the results in the table include only parous women. The analyses of groups 1-4 relate to the method of contraception stopped to enable pregnancy to occur; they replicate and extend the main analyses described earlier.' As before, there is clear evidence of impairment of fertility 12 months after stopping contraception in the group taking an oral contraceptive and a suggestion of some impairment in those using an intrauterine device. Differences between the groups are, however, less pronounced at 18 months and minimal from 24 months onwards. In groups 5 and 6 women stopping a contraceptive method to plan a pregnancy are divided into those "everusing" and those "never-using" an intrauterine device. Differences between the groups are small, but the percentage remaining undelivered at 42 months is slightly higher in the ever-users. Groups 7 and 8 correspond to groups 5 and 6, but women ever using an oral contraceptive have been omitted. Differences between the groups are minimal, especially from 18 months onwards. Group 9 consists of women who, at some time, had a device removed for medical reasons (for example, pain, bleeding, discharge). The data suggest that this group might have fared a little worse than other users of intrauterine devices, but even so only 13-6o/, remained undelivered at 24 months.
We tried to analyse the data by type of device and duration of use, taking age and previous use of oral contraceptives into account as well. The numbers, however, were too few for reliable conclusions to be drawn.
Comment
The data presented here reinforce our earlier findings' and those of others2 that parous women having an intrauterine device removed to plan a pregnancy have no prolonged impairment of fertility. Our results also provide some reassurance that any impairment of fertility in parous women having a device removed for other reasons (including medical ones) is likely to be small. Women using intrauterine devices are known to be at an increased risk of pelvic inflammatory disease,4 which is often followed by infertility.5 Our data suggest, however, the pelvic inflammatory disease (overt or covert) of sufficient severity to impair fertility must be very uncommon in parous users of intrauterine devices. This conclusion must not, of course, be extrapolated to young unmarried nulliparous women, who are not represented in our study.
We thank Mrs P Brown, Miss C Henry, and the research assistants, doctors, and nurses working at the clinics for their loyal support. We are also grateful to the Medical Research Council for financial assistance. 
